Skip to main content
OpenTrials

Clinical trial condition

Primary Immunodeficiency Diseases

Explore clinical trials studying Primary Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

254 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Primary Immunodeficiency Diseases trial results

Completed

C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

NCT00289211

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Clinical Research Consultants, Inc Hoover, Alabama, United States
  • Allergy and Immunology Associates Scottsdale, Arizona, United States
  • UCLA-David Geffen School of Medicine Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
View all 37 locations
View Trial Details
Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

NCT00462709

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Clinical Research Consultants, Inc Hoover, Alabama, United States
  • Allergy and Immunology Associates Scottsdale, Arizona, United States
  • Allergy and Asthma Clinic of Northwest Arkansas Bentonville, Arkansas, United States
  • UCLA-David Geffen School of Medicine Los Angeles, California, United States
View all 48 locations
View Trial Details
Completed

Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

NCT00456508

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Aaron Davis Scottsdale, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Little Rock Allergy & Asthma Clinic Little Rock, Arkansas, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
View all 41 locations
View Trial Details
Completed

Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

NCT02584959

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • AIRE Medical of Los Angeles Santa Monica, California, United States
  • Bay Area Allergy Walnut Creek, California, United States
  • IMMUNOe Research Centers Centennial, Colorado, United States
View all 27 locations
View Trial Details
Completed

A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema

NCT01386658

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of South Florida Tampa, Florida, United States
  • Breathe America Shreveport, Louisiana, United States
  • Institute for Asthma and Allergy, PC Chevy Chase, Maryland, United States
View all 26 locations
View Trial Details
Completed

Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema

NCT01059526

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Little Rock Allergry and Asthma Clinical Research Center Little Rock, Arkansas, United States
  • Sunrise Clinical Research Bell Gardens, California, United States
  • Allergy & Asthma Institute of the Valley Granada Hills, California, United States
  • Unidversity of California, Los Angeles David Geffen School of Medicine Los Angeles, California, United States
View all 40 locations
View Trial Details
Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

NCT00438815

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Allergy and Immunology Associates Scottsdale, Arizona, United States
  • Allergy and Asthma Clinic of Northwest Arkansas Bentonville, Arkansas, United States
  • UCLA-David Geffen School of Medicine Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
View all 30 locations
View Trial Details
Completed

Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

NCT02741596

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • AIRE Medical of Los Angeles Santa Monica, California, United States
View all 43 locations
View Trial Details

Related conditions